2019 Q2/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +8 Pfizer UK
7.5
2 -1 Cytogen
6.4
3 +0 Ligand Pharmaceuticals
6.3
4 +2 Shionogi
6.0
5 +7 Dainippon Sumitomo
5.8
6 +5 Yakult UK
5.6
7 +18 Galenica AG
5.5
8 +0 Baxter Healthcare UK
5.5
9 +134 Alcon
5.4
10 +5 Hetero
5.4
11 -1 Wockhardt
5.4
12 -4 Genus
5.3
13 +11 QLT
5.3
14 +12 Kyorin Holdings
5.3
15 -11 Zambon
5.2
16 +65 Medivir Group
5.2
17 +31 Debiopharm
5.1
18 +9 Abbott Uk
5.1
19 -5 GlaxoSmithKline
5.0
20 -1 Piramel Enterprises
5.0
21 +0 Bosnalijek
5.0
22 +14 Takeda UK
5.0
23 +0 EISAI UK
4.9
24 +7 Apotex
4.8
25 -20 Kyowa Hakko Kirin
4.8
26 +23 Recordati
4.8
27 +7 ALK-Abello
4.8
28 +11 Lexicon Pharmaceuticals
4.8
29 +6 Laboratoires Thea UK
4.8
30 +8 Lilly
4.7
31 +136 Patheon
4.7
32 +8 Bavarian Nordic
4.7
33 -20 Actelion
4.7
34 -18 Santen
4.6
35 -6 Zandu
4.6
36 +88 EISAI
4.6
37 -30 Baxter International
4.5
38 +78 Nippon Kayaku
4.5
39 -9 Toray Industries
4.5
40 -3 Acorda Therapeutics
4.5
41 +23 Esteve
4.5
42 +14 Mitsubishi Tanabe
4.5
43 +95 Teijin Europe
4.5
44 -11 ProMetric Life Sciences
4.5
45 +9 Bial Portela
4.5
46 +0 Wockhardt UK
4.4
47 -27 Takeda
4.4
48 +19 Santen Europe
4.4
49 +4 Leo Pharma UK
4.4
50 -22 Otsuka Pharmaceuticals Europe
4.3


Changes in rank are compared to 2019 Q1/Global Life Sciences. Since then, 3 sites entered the survey and 85 sites could not be included in the rankings (4 more since last time). Build your own. Report statistics.